Gene editing delivery biotech GenEdit partners with Genentech, raises another $24M

Kyle LaHucik

Senior Reporter

Gene editing still needs better delivery systems, more than half a dozen years after Kunwoo Lee recalls CRISPR pioneer Jennifer Doudna telling attendees at a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Gene editing delivery biotech GenEdit partners with Genentech, raises another $24M

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Gene edit­ing de­liv­ery biotech GenEd­it part­ners with Genen­tech, rais­es an­oth­er $24M

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Gene editing delivery biotech GenEdit partners with Genentech, raises another $24M